1st OTC Drug Approved for Women With Overactive Bladder

FRIDAY, Jan. 25 (HealthDay News) -- The drug Oxytrol has been approved by the U.S. Food and Drug Administration as the first over-the-counter treatment for women 18 and older with overactive bladder.

Overactive bladder is characterized by symptoms including leakage, frequent urination and feeling the sudden and urgent need to urinate. The condition affects some 33 million Americans, mostly older women.

Oxytrol contains oxybutynin, among a class of drugs called anticholinergics that are designed to relax the bladder muscle. Oxytrol is a patch applied to the skin every four days, the FDA said in a news release.

The drug will remain available for adult men by prescription only, the agency said.

Side effects reported during clinical testing included skin irritation at the patch site, dry mouth and constipation.

Oxytrol for Women is marketed by Merck, based in Whitehouse Station, N.J.

More information

To learn more about overactive bladder, visit the U.S. Department of Health and Human Services.

Related Articles

Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.

Health News is provided as a service to Sharp Web site users by HealthDay. Sharp HealthCare nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please read the Terms of Use for more information.